Your browser doesn't support javascript.
loading
Implication of clinical target delineation for T1b/T2 thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases.
Guan, Hui; Yu, Yang; Ge, Hong; Zhu, Shuchai; Huang, Wei; Li, Baosheng.
  • Guan H; Department of Radiation Oncology, The Fourth People's Hospital of Jinan, Jinan 250031, PR China.
  • Yu Y; School of Medicine & Life Sciences, Shandong Academy of Medical Sciences, University of Jinan, Jinan 250031, PR China.
  • Ge H; Department of Radiation Oncology, Henan Tumor Hospital, Zhengzhou 450008, PR China.
  • Zhu S; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, PR China.
  • Huang W; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong 250117, PR China.
  • Li B; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong 250117, PR China.
Future Oncol ; 15(29): 3345-3355, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31578872
ABSTRACT

Aim:

This study aimed to explore different patterns of lymph node metastases (LNM) in T1b and T2 thoracic esophageal squamous cell carcinoma (ESCC), and to further clarify its significance in radiotherapy target delineation. Materials &

methods:

Data of 1960 patients with T1b and T2 thoracic ESCC treated at different cancer centers were retrospectively analyzed. All patients underwent esophagectomy and lymphadenectomy. χ2 test and multivariate analysis were applied for analyzing clinicopathological factors related to LNM.

Results:

Age, location, tumor length, T stage and pathological grade were significantly associated with LNM (p < 0.01). For T1b ESCC, LNM rates in all sites were below 15%. For T2 upper thoracic ESCC, LNM rates were over 15% in upper mediastinal (15.8%). For T2 middle thoracic ESCC, LNM rates were middle mediastinal (17.2%) and abdominal (15.5%). For T2 lower thoracic ESCC, LNM rates were lower mediastinal (24.9%) and abdominal (22.5%). Subgroup analysis of T2 middle thoracic ESCC demonstrated that for patients older than 60 years, tumor length <4 cm and tumors were well differentiated. The LNM rates for abdominal were 11.9, 12.7 and 9.9%.

Conclusion:

Given the different patterns of LNM between T1b and T2 thoracic ESCC, target delineation should be adjusted accordingly.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Torácicas / Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Torácicas / Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article